WHA.AU · Wattle Health Australia Limited

-

Please sign in to comment on WHA.AU

1 Comment

Admin

3 years, 7 months ago

Wattle Health Australia Limited is currently in a long term downtrend where the price is trading 4.4% below its 200 day moving average.

From a valuation standpoint, the stock is 1810.0% more expensive than other stocks from the Consumer Defensive sector with a price to sales ratio of 129.7.

Wattle Health Australia Limited's total revenue rose by 38.1% to $714K since the same quarter in the previous year.

Its net income has dropped by 75.7% to $-17M since the same quarter in the previous year.

Finally, its free cash flow grew by 91.2% to $-2M since the same quarter in the previous year.

Based on the above factors, Wattle Health Australia Limited gets an overall score of 2/5.

ISIN	AU0000162281
Industry	Packaged Foods
Sector	Consumer Defensive
CurrencyCode	AUD
Exchange	AU

Beta	0.65
Dividend Yield	0.0%
Target Price	None
PE Ratio	None
Market Cap	109M

ABOUT

Wattle Health Australia Limited

Wattle Health Australia Limited produces and sells organic nutritional milk products in Australia. The company offers a range of nutritional infant formula dairy products under the Uganic brand name. It also provides organic baby skincare products, aromatherapy essential oils, and cleaning and laundry products under the Little Innoscents brand name. The company also sells its dairy products through online. Wattle Health Australia Limited has a strategic partnership with Shepparton Partners Collective. The company was founded in 2011 and is headquartered in Abbotsford, Australia.

WHA.AU · Wattle Health Australia Limited

-

Wattle Health Australia Limited

Earnings

Valuation

Cash Flow

Profitability

Performance

Backtest Wattle Health Australia Limited using a moving average strategy